Toward a Global Solution on Vaccine Liability and Compensation

March 28, 2019Food and Drug Law Journal

In the past five years, the global community has had to confront several deadly pandemics. These threats have generated increased attention to the need to promote robust vaccine development, which has the potential to reduce the dangers posed by these pandemics. To ensure robust vaccine development, it is important to address the liability concerns of vaccine manufacturers, which impede efforts to develop and distribute vaccines. Building on existing domestic and international models, we propose several approaches to protecting vaccine manufacturers from liability, while ensuring that those injured by vaccines are compensated.

To continue reading Cassye Cole, Jonah Wacholder and John Winter's article from the 74:1 issue of the Food and Drug Law Journal with permission of FDLI, please click here.